Author:
Predina J D,Judy B,Aliperti L A,Fridlender Z G,Blouin A,Kapoor V,Laguna B,Nakagawa H,Rustgi A K,Aguilar L,Aguilar-Cordova E,Albelda S M,Singhal S
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference44 articles.
1. 1. NCI Surveillance, Epidemiology, and End Results (SEER) Program. Nov 2009 Sub (1973-2007) 2. 2. edn. SEER Stat Database: Bethesda, MD, 2009.
3. Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005; 23: 4330–4337.
4. Juergens RA, Forastiere A . Combined modality therapy of esophageal cancer. J Natl Compr Canc Netw 2008; 6: 851–860; quiz 861.
5. Zhang X, Watson DI, Jamieson GG, Bessell JR, Devitt PG . Neoadjuvant chemoradiotherapy for esophageal carcinoma. Dis Esophagus 2005; 18: 104–108.